ÀÓ»ó½ÃÇè ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÑ ÀÚ·á·Î ½ÃÀå±Ô¸ð, »ê¾÷ºÐ¼®, ÇâÈÄ ½ÃÀå¿¹Ãø µîÀÇ ³»¿ëÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù.
![]() |
¼¼°èÀÇ ¿¬·É ¿ªÀü ÀÓ»ó½ÃÇè ½ÃÀå ¿¹Ãø(-2032³â) - Ä¡·á À¯Çüº°, ½ÃÇè ´Ü°èº°, ¹ÙÀÌ¿À¸¶Ä¿ À¯Çüº°, ¿¬±¸ µðÀÚÀκ°, ´ë»ó Áý´Üº°, ½ºÆù¼ À¯Çüº°, Áö¿ªº° ºÐ¼®
Age-Reversal Clinical Trials Market Forecasts to 2032 - Global Analysis By Therapy Type, Trial Phase, Biomarker Type, Study Design, Target Population, Sponsor Type and By Geography
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 4,150
![]() |
![]() |
¼¼°èÀÇ AR °øÆ÷Áõ Ä¡·á ½ÃÀå ¿¹Ãø(-2032³â) : °øÆ÷Áõ À¯Çüº°, ÄÄÆ÷³ÍÆ®º°, ¹èÆ÷ ¹æ½Äº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®
AR Phobia Treatment Market Forecasts to 2032 - Global Analysis By Phobia Type, Component, Deployment Mode, End User and By Geography
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 4,150
![]() |
![]() |
¼¼°èÀÇ À½¼º ±âºÐ Àå¾Ö Dx ½ÃÀå ¿¹Ãø : ±¸¼º¿ä¼Òº°, Àü°³ ¸ðµåº°, Áúȯ À¯Çüº°, ¹ÙÀÌ¿À¸¶Ä¿ À¯Çüº°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(-2032³â)
Voice Mood Disorder Dx Market Forecasts to 2032 - Global Analysis By Component (Solutions and Services), Deployment Mode (Cloud and On-premise), Disorder Type, Biomarker Type, Technology, Application, End User and By Geography
¹ßÇà 2025³â 09¿ù
°¡°Ý
US $ 4,150
![]() |
![]() |
ÀÓ»ó½ÃÇè Áö¿ø ¼ºñ½º ½ÃÀå : ¼ºñ½º À¯Çüº°, ´Ü°èº°, ½ºÆù¼½Êº°, ½ÃÇà ¸ðµ¨º°, Ä¡·á ¿µ¿ªº°, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Clinical Trial Support Services Market by Service Type, Phase, Sponsorship, Execution Model, Therapeutic Area, End-User - Global Forecast 2025-2030
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 3,939
![]() |
![]() |
ÀÓ»ó½ÃÇè ½ÃÀå : Á¦°ø, ½ÃÇè ¼³°è, ÀÓ»ó ´Ü°è, Åõ¿© ¸ðµ¨, Ä¡·á ¿µ¿ª, ½ºÆù¼½Êº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Clinical Trials Market by Offering, Trial Design, Clinical Phase, Delivery Model, Therapeutic Area, Sponsorship - Global Forecast 2025-2030
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 3,939
![]() |
![]() |
ÀÓ»ó½ÃÇè ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ¼ÒÇÁÆ®¿þ¾î À¯Çüº°, ºñÁî´Ï½º ¸ðµ¨º°, ÀÓ»ó ´Ü°èº°, Ä¡·á ºÐ¾ßº°, ±â´Éº°, µµÀÔ Çüź°, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Clinical Trial Software Market by Software Type, Business Model, Clinical Phase, Therapeutic Area, Functionality, Deployment Mode, End-User - Global Forecast 2025-2030
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 3,939
![]() |
![]() |
ÀÓ»ó½ÃÇè ¼ºñ½º ½ÃÀå : ¼ºñ½º À¯Çü, ½ÃÇè ´Ü°è, Ä¡·á ºÐ¾ß, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)
Clinical Trial Services Market by Service Type, Trial Phase, Therapeutic Areas, End User - Global Forecast 2025-2030
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 3,939
![]() |
![]() |
¼¼°èÀÇ Å¬¸®´ÏÄà ÀÎÅÚ¸®Àü½º ½ÃÀå
Clinical Intelligence
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ »ó½Ç¼ººó¹Ú ½ÃÀå
Supraventricular Tachycardia
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ °ú¹Î¼º Æó·Å ½ÃÀå
Hypersensitivity Pneumonitis
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ »ç¸£ÄÚÀ̵åÁõ Ä¡·áÁ¦ ½ÃÀå
Sarcoidosis Therapeutics
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ¸»ÃʽŰ溴Áõ Ä¡·á ½ÃÀå
Peripheral Neuropathy Treatment
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ¿ä¼Ò »çÀÌŬ Àå¾Ö Ä¡·á ½ÃÀå
Urea Cycle Disorder Treatment
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ °øÆ÷Áõ Ä¡·á ½ÃÀå
Phobia Treatment
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ±ÙÀ° °æ·Ã ½ÃÀå
Muscle Spasticity
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ Á¶¸°°Å-¿¤¸®½¼ ÁõÈıº Ä¡·á ½ÃÀå
Zollinger-Ellison Syndrome Treatment
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ÀÓ»ó½ÃÇè ¹× Á¦Á¦ ¾Æ¿ô¼Ò½Ì ½ÃÀå
Outsourced Clinical Trials and Formulation
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ºñÀÓ»ó½ÃÇè ½ÃÀå
Non-Clinical Trials
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ÇѼ¾º´ Ä¡·á ½ÃÀå
Leprosy Treatment
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ¿À¹Í½º ±â¹Ý ÀÓ»ó½ÃÇè ½ÃÀå
Omics-based Clinical Trials
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ºñµ¿¹°½ÇÇè ´ëü¹ý ½ÃÀå
Non-animal Alternative Testing
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
NPS+ (¹Ì±¹) - ¹Ì¸¸¼º °Å´ë B¼¼Æ÷ ¸²ÇÁÁ¾
NPS+ (US) - Diffuse Large B-Cell Lymphoma
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 8,000
![]() |
![]() |
¼¼°èÀÇ °¡»ó ÀÓ»ó½ÃÇè ½ÃÀå
Virtual Clinical Trials
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ÀÓ»ó½ÃÇè ¸ÅĪ ¼ÒÇÁÆ®¿þ¾î ½ÃÀå
Clinical Trials Matching Software
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |
![]() |
¼¼°èÀÇ ÀÓ»ó½ÃÇè Àåºñ ¹× º¸Á¶ ¼Ö·ç¼Ç ½ÃÀå
Clinical Trial Equipment and Ancillary Solutions
¹ßÇà 2025³â 08¿ù
°¡°Ý
US $ 5,850
![]() |